Atlas Trials

Primary Central Nervous System Lymphoma (PCNSL)

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Central Nervous System Lymphoma (PCNSL)

RecordFirmDate
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies (NCT05131022)Nurix Therapeutics, Inc.2022-04-13
High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma (NCT07014943)Sichuan University2022-01-01
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04830137)Nurix Therapeutics, Inc.2021-05-05
Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. (NCT04688151)National Health Research Institutes, Taiwan2021-02-22
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy (NCT04401774)Memorial Sloan Kettering Cancer Center2020-05-22
Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL) (NCT04253496)Assistance Publique - Hôpitaux de Paris2020-05-12
Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) (NCT03703167)Memorial Sloan Kettering Cancer Center2019-01-22

Track Primary Central Nervous System Lymphoma (PCNSL) automatically

Every clearance here is in the API, with alerts when new ones post.